Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis

Low selectivity of chemotherapy correlates with poor outcomes of cancer patients. To improve this issue, a novel agent, N-(1-[3-methoxycarbonyl-4-hydroxyphenyl]-β-carboline-3-carbonyl)-Trp-Lys-OBzl (PZL318), was reported here. The transmission electron microscopy, scanning electron microscopy, and a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nanomedicine
Main Authors: Li, Shan, Wang, Yuji, Wang, Feng, Wang, Yaonan, Zhang, Xiaoyi, Zhao, Ming, Feng, Qiqi, Wu, Jianhui, Zhao, Shurui, Wu, Wei, Peng, Shiqi
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554418/
https://ncbi.nlm.nih.gov/pubmed/26345234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S88052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados